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Abstract
Controlled localization of class II MHC molecules is essential for proper class II MHC-restricted antigen presentation and the
subsequent initiation of an adaptive immune response. Ubiquitination of class II MHC molecules on cytosolic lysine (K225) of
the b-chain has been shown to affect localization of the complex. We generated mice in which the endogenous b-chain
locus is replaced with a GFP tagged mutant version that lacks the cytosolic lysine residue (I-A-b-K225R-EGFP). These mice
have elevated levels of class II MHC as compared to I-A-b-EGFP mice, and immature bone marrow-derived dendritic cells
show redistribution of class II MHC to the cell surface. Nonetheless, in these same cells efficiency of antigen presentation is
unaffected in I-A-b-K225R-EGFP mice, as assayed for presentation of ovalbumin to appropriately specific T cells. The I-A-b-
K225R-EGFP animals have normal CD4 T cell populations and are capable of generating antigen-specific antibody in
response to model antigens and viral infection. We therefore conclude that in our experimental system modulation of
trafficking by ubiquitination of residue K225 of the b-chain is not essential for the function of class II MHC products in
antigen presentation or antibody production.
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Introduction
Class II major histocompatibility complex (MHC) molecules are
expressed by professional antigen presenting cells (APCs), and are
necessary for the presentation of antigenic peptides to CD4 T cells
and the subsequent initiation of an adaptive immune response.
The timing of class II MHC-dependent antigen presentation is
carefully controlled in order to achieve specificity of immune
responses; the regulated trafficking of class II MHC molecules is
one aspect of such control [1,2,3]. Ubiquitination of class II MHC
molecules has recently been identified as an important mechanism
that cells employ to regulate trafficking of class II MHC.
Class II MHC molecules can be ubiquitinated on a single lysine
residue that is present in the cytoplasmic tail of the b-chain (I-Ab-
K225) [4,5,6]. Modification of the class II MHC b-chain with
ubiquitin has been implicated in several steps of the trafficking
pathway, including internalization, endocytic trafficking, targeting
to multivesicular bodies and degradation [5,6,7]. Ubiquitination of
class II MHC molecules occurs at the plasma membrane of
immature dendritic cells resulting in recycling of class II molecules
from the cell surface to internal endosomal compartments. It has
been proposed that ubiquitination of class II MHC molecules is
also used by dendritic cells as a mechanism to control the
relocalization of class II MHC upon maturation [5]. Following
engagement of Toll like receptors, and possibly other receptors as
well, this ubiquitination is turned off or reversed, which results in
relocalization of class II MHC from internal compartments to the
cell surface of DCs [5]. This differential ubiquitination is achieved
through regulation of the ubiquitin ligase responsible for the
addition of ubiquitin to the class II MHC, the membrane-
associated RING-CH I (MARCH-I) [7,8,9]. Expression of
MARCH I is downregulated in human dendritic cells upon
maturation [8], leading to a corresponding increase in the cell
surface levels of class II MHC. In general, it appears that only a
minor fraction of class II MHC products is modified by
ubiquitination, with the caveat that biochemical methods are
likely to underestimate the true extent of modification.
In dendritic cells, internalization of class II MHC from the cell
surface is decreased when the cytoplasmic lysine of the b-chain is
mutated [6]. Additionally, class II MHC molecules that lack the
cytoplasmic lysine of the b-chain display a decreased localization to the
internal vesicles of multivesicular bodies, suggesting that ubiquitination
is important as a signal for the inclusion of class II MHC in these
internal vesicles [5,6]. Mice deficient in MARCH I show internaliza-
tion of class II MHC from the cell surface of B cells, but have defects in
delivery of class II MHC to acidic compartments, implying that
ubiquitination may be important in the trafficking of class II MHC
fromearlyendosomesto endolysosomes[7].Ubiquitinationisprobably
also important for degradation of class II MHC, since cells with
mutations in either MARCH I or the cytoplasmic lysine of the b-chain
all showed increased levels of class II MHC, but no obvious increase in
the rate of synthesis of class II MHC [5,6,7].
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of class II MHC dramatically affects its trafficking. These
previously published reports have not, however, addressed the
physiological role of this modification in vivo in the context of
the immune system. In order to address this issue we generated a
targeting construct with a mutant class II MHC b-chain tagged
with EGFP in which the single cytosolic lysine was replaced by
an arginine (K225R). This construct was knocked-in to the
endogenous I-Ab locus, creating the I-Ab-K225R-EGFP mouse.
We show that I-Ab-K225R-EGFP mice retain normal popula-
tions of CD4 T cells and B cells, display unaltered efficiency of
antigen presentation in vitro and are capable of in vivo
generation of antibody responses.
Results
Generation of I-A-b-K225R-EGFP mice
Ubiquitination of class II MHC regulates the localization of
class II MHC molecules in both B cells and dendritic cells (DCs)
[4,6,7]. In order to study the role of ubiquitination on the function
of class II MHC molecules in vivo and in vitro, we generated a
knock-in mouse model in which the endogenous class II MHC
locus was replaced by a construct that encodes a mutant class II
MHC b-chain that cannot be ubiquitinated (K225R).
The I-A
bb locus was previously targeted to generate an I-Ab-
EGFP expressing mouse [10]. We chose to follow a similar strategy
to generate I-Ab-K225R-EGFP mice (Figure 1A). A construct was
used in which the long arm of homology corresponds to exons 2–4
of the I-A
bb locus, followed by fused exons 5 and 6, in frame to the
coding region for EGFP. The K225R mutation in the cytoplasmic
tail of class II MHC was introduced into exon 4 of this construct.
The long arm of homology and a short arm of homology
corresponding to the 39 untranslated region (UTR) of I-Ab were
cloned into the pACN-TV targeting vector. pACN-TV contains a
self-excisable ACN cassette that consists of a neomycin resistance
gene, and a gene for Cre recombinase under the control of a
sperm-specific promoter flanked by loxP sites [11]. Transcriptional
induction of the ACN cassette leads to the excision of the
neomycin resistance gene and Cre recombinase when the gene is
transmitted through the male germline.
Figure 1. Generation of I-A-b-K225R-EGFP mice. A, Schematic of the approach used to target the I-A
b-b locus. The exon structure of the I-A
b-b
locus is shown with the locations of the signal peptide (SP), extracellular domain (Extracellular), transmembrane domain (TM), and cytoplasmic tail
(Cytoplasmic) indicated. The targeting construct consisted of a long arm of homology (LAH) consisting of exons 2–4, the K225R mutation introduced
into exon 4, exons 5 and 6 fused to each other and to EGFP, a floxed self-excisable neomycin resistance cassette and a short arm of homology (SAH)
consisting of the 39UTR. Not drawn to scale. B, Splenocytes from I-A-b-EGFP or I-A-b-K225R-EGFP mice were stained with antibodies to detect B cell
(B220), dendritic cell (CD11c) and T cell (CD3) populations and were analyzed by flow cytometry. Class II MHC, as detected from EGFP fluorescence,
was present in B cells and dendritic cells, and class II MHC levels were increased in cells isolated from I-A-b-K225R-EGFP mice. C, Total splenocytes
were isolated from heterozygous I-A-b-EGFP/HA-Ub and I-A-b-K225R-EGFP/HA-Ub mice and subjected to immunoprecipitation with an antibody
against the MHC II a chain and subsequently to immunoprecipitation with an antibody against GFP. Total lysates were subjected to SDS-PAGE and
immunoblot analysis with anti-GFP and anti-HA. All experiments were performed at least twice; representative experiments are shown.
doi:10.1371/journal.pone.0018817.g001
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Southern blotting, were injected into blastocysts to generate
chimeric mice, which were then bred to obtain germline
transmission of the targeted I-Ab locus. The generation of the I-
Ab-K225R-EGFP mice was confirmed by sequencing of exon 4 of
I-Ab, which showed that the I-Ab locus in these mice does in fact
harbor the K225R mutation.
The mice that received the I-Ab-K225R-EGFP targeted allele
were analyzed by flow cytometry to assess the cell specific
distribution of GFP fluorescence. In splenocytes from both control
I-Ab-EGFP mice and I-Ab-K225R-EGFP mice, all of the B220
positive B cells and CD11c positive DCs in the spleens of I-Ab-
K225R-EGFP mice were positive for GFP, while none of the CD3
positive T cells expressed GFP (Figure 1B) indicating that
expression of the I-Ab-K225R-EGFP construct was correctly
restricted to the B cell and DC lineages. We consistently observed
that the level of GFP fluorescence was higher in cells from I-Ab-
K225R-EGFP mice as compared to I-Ab-EGFP controls (see
below).
In order to confirm that the K225R mutation abolished
ubiquitination of class II MHC molecules we crossed I-Ab-EGFP
and I-Ab-K225R-EGFP mice with mice that express HA-tagged
ubiquitin [12]. We isolated splenocytes from these I-Ab-EGFP/
HA-Ub (WT/HA-Ub) and I-Ab-K225R-EGFP/HA-Ub (KR/
HA-Ub) mice and immunoprecipitated the class II MHC complex
with an antibody directed against the a chain (JV1). The eluate
was used in a second immunoprecipitation with an antibody
directed against GFP. Total lysates and immunoprecipitates were
analyzed by SDS-PAGE and immunoblotting to detect the GFP-
tagged class II MHC b chain (Figure 1C, upper panel) and HA-
reactive material (Figure 1C, lower panel). We could detect a
specific HA-reactive band that was present in the I-Ab-EGFP
splenocytes, but absent from the I-Ab-K225R-EGFP splenocytes.
The molecular weight of the observed HA-reactive band
corresponds to the expected molecular weight of the I-Ab-EGFP
conjugated with a single ubiquitin. We conclude that the K225R
mutation prevents class II MHC b chain ubiquitination in I-Ab-
K225R-EGFP mice.
Surface and total levels of class II MHC are increased in
KR mice
Altered ubiquitination of class II MHC molecules has been
linked to changes in the levels of class II MHC that are present in
the cell [5,6,13]. To determine the effect of blocking ubiquitina-
tion of endogenously expressed class II MHC we examined the
levels of class II MHC in both B cells and DCs by flow cytometry
(Figure 2A). Surface levels of class II MHC were increased in I-Ab-
K225R-EGFP mice compared to both BL6 and I-Ab-EGFP mice.
Figure 2. Total and cell surface levels of class II MHC are increased in I-A-b-K225R-EGFP mice. A, Splenocytes from B6 (+), I-A-b-EGFP (WT)
and I-A-b-K225R-EGFP (KR) mice were analyzed by flow cytometry for class II levels. Total levels of class II MHC were determined from GFP
fluorescence and the levels of cell surface class II MHC was assessed by staining with antibodies against I-A-b. Total and cell surface levels of class II
MHC are increased in both B cells and dendritic cells of I-A-b-K225R-EGFP mice relative to I-A-b-EGFP and B6. This analysis was performed 3 times with
a total of 8 mice of each genotype; representative data are shown. B, Splenocytes were lysed in NP40 and analyzed by SDS-PAGE. Samples were either
boiled, or incubated at room temperature (non-boiled) to distinguish between the class II MHC complex and free I-Aa and I-Ab chains. GFP-tagged I-
Ab was detected with antibodies against GFP, while the untagged I-Ab was detected with the JV2 antibody. Levels of the mutant I-Ab increased in I-
A-b-K225R-EGFP cells while wild type I-A-b levels in the same cells remained constant. C, Cells were analyzed as in B, and immunoblotted with
antibodies directed against I-Aa. Levels of I-Aa increase in I-A-b-K225R-EGFP cells showing that both components of the class II MHC molecule are
affected. Immunoblotting analysis was performed at least twice; representative data are shown.
doi:10.1371/journal.pone.0018817.g002
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Ab-K225R-EGFP mice were greater than those from the I-Ab-
EGFP mice indicating that the change in surface levels reflects an
overall change in levels of class II MHC, and not merely a relative
relocalization of these molecules to the cell surface.
To confirm that the overall levels of class II MHC were
increased in the I-Ab-K225R-EGFP mice, we analyzed protein
lysates from splenocytes by SDS-PAGE and immunoblotting
(Figure 2B and 2C). Lysates were either boiled in SDS-PAGE
sample buffer in order to assess single class II MHC subunits, or
were not boiled in order to preserve a/b/invariant chain (Ii) and
a/b/peptide complexes. In heterozygous mice that express both
untargeted I-Ab allele and a targeted I-Ab- EGFP or I-Ab-
K225R-EGFP allele, we observed that levels of the wild type allelic
product remain constant, as concluded from immunoblotting with
the JV2 antibody, which recognizes the cytoplasmic tail of I-Ab
and does not recognize the EGFP tagged I-Ab. Levels of the
mutant I-Ab-K225R-EGFP protein were elevated compared to
levels of I-Ab-EGFP, as determined from immunoblotting against
the EGFP tag. Finally, I-Aa levels were also increased in I-Ab-
K225R-EGFP mice (Figure 2C). For both I-Aa and I-Ab-EGFP
greater differences were seen in the non-boiled samples, indicating
that it is indeed the class II MHC complex as such that is targeted
by ubiquitination, and not simply unpaired I-Ab chains.
KR mice show normal synthesis and maturation of class II
MHC
The increase in class II MHC levels in I-Ab-K225R-EGFP mice
could be caused by a change in the synthesis, maturation or
degradation of class II MHC. We analyzed cells from these mice by
metabolic labeling in a pulse chase experiment, followed byimmu-
noprecipitation (Figure 3). Rates of synthesis of class II MHC were
similar in both cell types and the appearance of SDS-resistant a/b/
peptidecomplexesoccurred with comparable kinetics inthetwo cell
types (Figure 3A), indicating that trafficking to peptide loading
compartments and maturation of class II MHC molecules are not
affected by the I-Ab-K225R-EGFP mutation. Ubiquitination is
therefore not required for maturation of class II MHC molecules.
Since ubiquitination has been implicated in the degradation of
class II MHC molecules [5], we wanted to address whether the
degradation of class II MHC molecules is altered in I-Ab-K225R-
EGFP mice. In order to address this question we looked at later time
points in our metabolic labeling experiments and quantified the
recovery of labeled proteins after immunoprecipitation with
antibodies directed against I-Aa (Figure 3 B–D). At early time points
after radiolabeling (1 and 3 hours) recovery of I-Ab and Ii increased
in both WT and KR mice, presumably due to the increased
generation of a/b/Ii complexes. At later time points (6 and 9 hours)
recovery of Ii decreased dramatically, suggesting that the class II
MHC complexes had reached a cellular compartment in which the Ii
was degraded (Figure 3B and 3D). This was true for both WT and
KR mice, providing further evidence that the maturation of class II
MHC molecules is normal in the I-Ab-K225R-EGFP mice.
Reduction of I-Ab, presumably a result of class II MHC complex
degradation, was seen in both WT and KR mice; however, the
degradation of class II MHC tended to be greater in the WT mice
( F i g u r e3 Ba n d3 C )i nt h et h r e et i m e st h a tt h i se x p e r i m e n tw a s
performed, but the differences did not reach statistical significance.
KR mutation affects the subcellular localization of class II
MHC molecules
In order to determine the effects of ubiquitination on the
localization of class II MHC molecules, we performed confocal
microscopy on live bone marrow-derived dendritic cells (BMDCs).
We took advantage of the fact that our targeted mice expressed
EGFP tagged I-Ab to allow us to visualize both wild type and
K225R mutant I-Ab in the same cell simultaneously. Dendritic
cells that had been cultured for 5 days from either I-Ab-EGFP or
I-Ab-K225R-EGFP mice were transduced with lentiviral vectors
that express either I-Ab-K225R-Cherry or I-Ab-Cherry, respec-
tively, to enable simultaneous imaging (Figure 4). Since the
localization of class II MHC molecules changes upon dendritic cell
maturation it is possible to use the localization of class II MHC
molecules to assess the maturation state of dendritic cells. We
therefore used the endolysosomal localization of our wild type
fluorophore-tagged class II MHC molecules as a marker to
identify immature dendritic cells. Localization of I-Ab-K225R to
the cell surface was dramatically increased, while localization to
the endolysosomal compartments was decreased compared to the
wild type construct (Figure 4). Localization of I-Ab and I-Ab-
K225R are not affected by either the kind of fluorescent tag that is
used to visualize the molecules (EGFP vs Cherry), or by the
expression system (endogenous vs. lentiviral).
Immune cell populations are not affected by KR mutation
Disrupting the ubiquitination of class II MHC molecules alters
both the total levels of class II MHC and their distribution. Does
this change in class II MHC dynamics affect the function of class
II MHC? We started to address this question by surveying
lymphocyte populations in both I-Ab-EGFP and I-Ab-K225R-
EGFP by flow cytometry. Total numbers and percentages of
splenic B cells (B220), CD4 T cells, CD8 T cells and dendritic
cells (CD11c) were comparable between the I-Ab-EGFP and I-
Ab-K225R-EGFP mice (Figure 5). In addition immune cells
from thymus, bone marrow, lymph nodes and the peritoneal
cavity were analyzed yielding no detectable differences between
the two mice (data not shown). Because class II is important for
T cell development [14], we monitored populations of CD4 and
CD8 negative, single positive and double positive T cells isolated
from the thymus. However, no differences were detectable. In
bone marrow we investigated development of B cells from the
early pre pro-B cell through pre-B cell stages according to the
staining scheme proposed by Hardy et al. [15]. In lymph nodes,
spleen, and the peritoneal cavity we looked at total populations
of B cells (B220), T cells (CD4 and CD8) and dendritic cells
(CD11c). In conclusion, none of the investigated cell populations
were altered in I-Ab-K225R-EGFP mice as compared to I-Ab-
EGFP controls.
Antigen presentation is not affected by KR mutation
We next investigated antigen presentation by bone marrow-
derived DCs from I-Ab-K225R-EGFP mice. At day 5 the majority
of BMDCs were immature as judged by low levels of cell surface
CD80, and no difference was observed between the WT and KR
dendritic cells (data not shown). These Day 5 BMDCs were
incubated with ovalbumin (Ova) and were subsequently fixed.
Fixed BMDCs were then incubated overnight with T cells isolated
from OTII mice, whose T cell receptor recognizes the Ova 323–
339 peptide-class II MHC complex. Activation of CD4 T cells was
measured by upregulation of the cell surface marker CD69
(Figure 6). Antigen presentation by BMDCs to OTII T cells was
unaffected in DCs from I-Ab-K225R-EGFP mice. Titration of
Ova added to the cells (Figure 6A), or alteration of the time
allowed for processing prior to fixation (Figure 6B) did not reveal
any differences in the efficiency of antigen presentation between I-
Ab-EGFP and I-Ab-K225R-EGFP mice.
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Class II MHC molecules play an essential role in the T cell-
dependent antibody response. If correct class II MHC homeostasis
is important for these responses then the altered class II MHC
dynamics in I-Ab-K225R-EGFP mice could affect the ability of
animals to produce antibodies.
We measured the levels of IgA, IgG1, IgG2a, IgG2b, IgG3 and
IgM in serum from 129, I-Ab-EGFP, and I-Ab-K225R-EGFP
mice (Figure 7A). No differences were noted in the serum levels in
any of the immunoglobulin isotypes, except for an increase in
IgG2a in the I-Ab-K225R-EGFP mice. However, since the higher
IgG2a titers were also present in 129 mice, and the I-Ab-K225R-
EGFP mice are on a mixed 129/BL6 background, this difference
is likely to be attributable to a difference in strain background
rather than to the difference in I-Ab.
In order to assess antigen-specific immunoglobulin production,
mice were immunized with Ova and hen egg lysozyme (HEL).
Serum was isolated from mice prior to immunization, again after a
4-week course of immunization, and was then analyzed for the
presence of HEL- and Ova-specific IgG (Figure 7B–C). The
antigen-specific IgG response varied between individual mice of
each group, but we did not observe changes in the antibody
response between the two groups of mice.
In order to test the ability of the I-Ab-K225R-EGFP mice to
generate an antibody response under more physiologically relevant
infection conditions we assessed their ability to produce antibodies
Figure 3. Synthesis and maturation of class II MHC is normal in I-A-b-K225R-EGFP mice. A, Splenocytes were pulsed with [
35S]-cystine/
methionine for 30 minutes and chased for the indicated times. Immunoprecipitations were performed with the I-Aa-specific antibody JV1,
precipitates were eluted at room temperature (left panel) or boiled (right panel). B, Experiments were performed as in (A), immunoprecipitates were
boiled to elute samples. C and D, Quantification of the b-EGFP and Ii-p31 data in (B). Closed circles: I-A-b-EGFP, open circles: I-A-b-K225R-EGFP. These
experiments were performed three separate times; representative data is shown.
doi:10.1371/journal.pone.0018817.g003
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antibody response was measured 14 days after inoculation with the
influenza virus. There was no difference in the generation of
influenza-specific IgG between I-Ab-EGFP and I-Ab-K225R-
EGFP mice (Figure 7D). In conclusion, our results indicate that the
I-Ab-K225R-EGFP mice are able to produce an antigen-specific
response after both immunization and viral infection that is
comparable to wild type at this level of analysis.
Discussion
Previous studies have shown that class II MHC is ubiquitinated
on the b-chain, which helps control the localization and expression
of class II MHC molecules [4,5,6]. These previously published
results were obtained in cultured cells and did not address the
physiological role of class II MHC ubiquitination in vivo.
In order to understand the role of class II MHC ubiquitination
in the context of the immune system we generated a mouse in
which the endogenous I-Ab locus was replaced with a mutant
version of I-Ab that lacks the cytosolic lysine residue that is
essential for ubiquitination (I-Ab-K225R-EGFP). As expected, we
found that the K225R mutation abolishes ubiquitination of the
class II MHC b chain in splenocytes. I-Ab-K225R-EGFP mice
have increased class II MHC levels due to decreased degradation,
and show an altered distribution of class II MHC between
endolysosomal compartments and plasma membrane in immature
bone marrow-derived dendritic cells.
Several possibilities can be envisioned for how altered trafficking
dynamics might affect class II MHC function: altered dynamics of
class II MHC recycling may affect the ability to present antigens to
T cells, alterations in the levels and efficiency of class II MHC
molecules in the thymus could lead to skewing of the overall CD4
T cell population. In the context of an immune response, the
ability of animals to produce antibodies in response to antigen
challenge could be altered.
However, altered localization and trafficking of class II MHC in
bone marrow derived dendritic cells from I-Ab-K225R-EGFP
mice did not affect antigen presentation to T cells, notwithstanding
increased levels of class II MHC at the plasma membrane. Perhaps
the population of class II MHC that is ubiquitinated is intended
for degradation, or destined for some other fate that is not
immediately relevant for the efficiency of antigen presentation in
BMDCs.
A recent report by Ohmura-Hoshino et al. [16] addressed the
role of class II MHC ubiquitination in cytokine secretion and
antigen presentation by dendritic cells. These authors found that
dendritic cells isolated from the spleens of either MARCH I
ubiquitin ligase knock out animals, or K225R knock-in animals
had defects in the secretion of IL-12 and TNF-a, and in the
presentation of ovalbumin to OTII T cells. Surprisingly, bone
marrow derived dendritic cells from these same animals did not
show any alterations in IL-12 secretion. However the ability of
these BMDCs to present antigens was not addressed in the paper.
We found that BMDCs are equally capable of antigen presenta-
tion regardless of whether they express wild type or K225R I-Ab.
However, the distribution of I-Ab-EGFP in immature bone
marrow derived dendritic cells is clearly affected by the K225R
mutation. These results suggests that antigen presentation itself is
not affected by ubiquitination of class II MHC, at least not in a
way that can be read out by the assays used here.
The differences in antigen presentation between splenic and
bone marrow-derived DCs observed by Ohmura-Hoshino et al.
may be partially attributable to differences in DC development. In
addition, MARCH I may well target substrates other than class II
MHC. Using our in vitro differentiation protocol we have
bypassed the effects of DC interaction with the splenic microen-
vironment, and thus we can argue that our system allows us to
directly investigate the effect of class II MHC ubiquitination on
antigen presentation, rather than on dendritic cell development.
We found that development and numbers of CD4 and CD8 T
cells are normal in the I-Ab-K225R-EGFP mice. If the dendritic
cells in the thymus were defective in antigen presentation a change
in the number of CD4 T cells would be expected [17], however
this is not the case, indicating that differential localization of class
II MHC does not measurably affect CD4 T cell selection.
Additionally, we find that antibody responses are normal in
mice that cannot ubiquitinate class II MHC. Antibody generation
requires efficient class II MHC-mediated antigen presentation by
both B cells and dendritic cells, and thus the ability of the I-Ab-
K225R-EGFP to generate antibody responses indicates that in
vivo the level of antigen presentation by class II MHC is sufficient
at least to support the antibody response.
In conclusion, our experiments yielded no evidence that the
alterations in class II MHC levels and their trafficking affected
efficiency of antigen presentation per se, or the ability of mice to
generate antibody responses. As previously published results imply
a role for class II MHC ubiquitination in the regulation of
dendritic cell functions in vivo [16], further studies of in vivo
immune responses are necessary to elucidate the effects of altered
class II MHC dynamics on the immune system.
Materials and Methods
Mouse Lines
C57BL/6J mice were obtained from The Jackson Laboratory. I-
Ab-EGFP mice [10] HA-Ub mice [12] and OTII mice [18] have
been described. All animals were maintained according to the
guidelines of the MIT Committee on Animal Care (CAC). These
studies were approved by the MIT CAC (protocol #1005-070-08).
Figure 4. I-A-b-K225R-EGFP is redistributed to the cell surface.
BMDCs from I-A-b-EGFP were transduced with I-A-b-K225R-Cherry and
the localization of both molecules was visualized by confocal
microscopy (top panels). This experiment was performed on four
separate occasions. 39 cells expressing both proteins were visualized
and 85% of these showed increased surface localization of I-A-b-K225R-
Cherry compared to I-A-b-GFP. Representative pictures are shown. The
bottom panels show the converse experiment in which I-A-b-K225R-
EGFP BMDCs were transduced with I-A-b-Cherry. This experiment was
performed twice and the results were similar to those in the converse
experiment. Representative pictures are shown.
doi:10.1371/journal.pone.0018817.g004
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Bone marrow dendritic cells (BMDCs) were prepared by
isolating cells from the femurs and tibias of mice. Cells were
cultured in DMEM (Invitrogen Life Technologies) supplemented
with 10% FBS, penicillin/streptomycin, 10 ng/ml recombinant
mouse GM-CSF (Peprotech), and 1 ng/ml recombinant mouse
IL-4. Media was partially replaced every two days. BMDCs were
used for experiments after 5 days in culture.
ES cell targeting and mouse generation
The targeting vector pACN-TV [11] was used for the
construction of the I-Ab-K225R-EGFP targeting construct. The
long arm of homology consisted of a region spanning exons 2–4,
exons 5–6 were fused together and also fused to EGFP, the short
arm of homology consisted of the 39 untranslated region of the
class II MHC mRNA, these were the same as used previously [10].
The K225R mutation was introduced into the long arm of
homology in pBluescript using the Quickchange XL kit from
(Stratagene) and the primers: fwd-CCGTCACAGGAGTCAGA-
GAGGTGAGGAGCTC, rev-GAGCTCCTCACCTCTCTGA-
CTCCTGTGACGG. The long arm of homology was inserted
upstream of the ACN cassette, while the short arm of homology
was inserted downstream of the ACN cassette. The diptheria toxin
(DT) negative selection marker was cloned from this pACN-TV
and a second DT gene was added into the construct after the
short arm of homology so that the targeting construct was flanked
by DT selection genes. Linear targeting constructs were
introduced into C57BL/6J/129 F1 ES cells [19]. Positive ES
cells were selected for by the presence of neomycin, and were
then screened by PCR for the presence of the correctly targeted
short arm of homology, the sequences of the primers used were:
fwd-GATTCGCAGCGCATCGCCTTCTATC, rev-GTCAGC-
TGCACCACTTCTGTTAGGTCTCAC. The positive ES cell
lines were further screened by southern blotting for the correctly
targeted long arm of homology using the neomycin resistance
gene as a template for probe generation. The generation of the I-
Ab-K225R-EGFP mice was confirmed by sequencing of exon 4
of I-Ab using the following primers to amplify the region, and
the fwd primer to sequence the region: fwd-TATACACTGG-
GGCCCTGGAACTTG and rev-CAGCTCCTCGCCCTTG-
CTCAC.
Figure 5. Immune cell populations are not affected in I-A-b-K225R-EGFP mice. Splenocytes from B6 (+/+), I-A-b-EGFP (WT/WT) and I-A-b-
K225R-EGFP (KR/KR) mice were isolated, stained with the indicated antibodies and analyzed by flow cytometry. Shown are data from a representative
experiment. This analysis was performed 3 separate times on a total of 8 mice of each genotype.
doi:10.1371/journal.pone.0018817.g005
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I-Ab-EGFP mice[10] and I-Ab-K225R-EGFPmicewerecrossed
with mice expressing hemagglutinin-tagged ubiquitin (HA-Ub) [12].
Total splenocytes were lysed in Nonidet P-40 buffer (25 mM Tris
pH 7.4, 150 mM NaCL, 5 mM MgCl2, 0.5% NP40) supplemented
with protease inhibitor cocktail (Roche) and 10 mM N-Ethylmalei-
mide (NEM). The I-Ab complex was immunoprecipitated with JV1
antiserum (directed against the class II MHC a chain) and ProtA
beads (Repligen). The protein complex was eluted off the beads by
addition ofa small volumeNP40bufferwith 1% SDS,20 mMDTT
and10 mM NEM. The eluate was subjected to a second round of
immunoprecipitation with an antibody directed against GFP
(Abcam) and ProtA beads. Total lysates and immunoprecipitates
were subjected to SDS-PAGE and immunoblot analysis.
Lentivirus preparation and transduction
Virus preparation and transductions were performed as
described previously [20]. Briefly, virus was produced in human
embryonic kidney (HEK) cells 293T (American Type Culture
Collection; CRL-11268) and viral supernatants were concentrated
by centrifugation. Virus was added to BMDCs after 2 days in
culture. After 12 h of infection, the medium was replaced with
fresh medium. BMDCs were used at day 5.
Confocal Microscopy
Images were acquired using a spinning disk confocal microscope
and a 3-W water-cooled laser with an acoustic-optic tunable filter
(Prairie Technologies). The system incorporated a Nikon TE2000-
U inverted microscope using a Nikon 6100 magnification, 1.4
numerical aperture, differential interference contrast oil lens.
Nikon type A immersion oil was used (Nikon). Images were
acquired and processed using Metamorph software (Molecular
Devices). Images were subsequently cropped in Adobe Photoshop
and figures were constructed in Adobe Illustrator.
FACS analysis
Cells were incubated with Fc block antibody (BD Pharmingen)
before FACS staining. Antibodies used for FACS staining were anti
B220-PerCP-Cy5.5, anti B220-APC, anti CD11c-APC, anti CD3-PE,
anti CD4-APC, anti CD8-PerCP-Cy5.5, CD69-PE, anti-I-A
bb-PE
(BD Pharmingen). Data were collected on an LSR II flow cytometer
(BD Biosciences) and analyzed with FlowJo software (TriStar).
Metabolic labeling and immunoprecipitation
Pulse-chase experiments were performed as described [21]. Briefly,
isolated B cells were starved in methionine- and cysteine-free media,
then pulse-labeled with [
35S]-methionine/cystine (Perkin-Elmer) for
30 minutes. After labeling, cells were incubated in chase medium
containing unlabeled methionine (2.5 mM) and cysteine (0.5 mM).
Attheend ofeachchaseinterval,cellswerelysedinNP-40lysisbuffer
(50 mM Tris, pH 7.4, 0.5% NP-40, 5 mM MgCl2, 150 mM NaCl,)
supplemented with protease inhibitor cocktail (Roche). Lysates were
then analyzed by immunoprecipitation with rabbit anti-I-Aa serum
(JV1) [22] and subjected to SDS-PAGE and fluorography.
Quantitation was performed using a phosphorimager, and ImageJ
analysis software (National Institute of Health).
Cell lysis and immunoblotting
Cells were lysed in NP-40 lysis buffer supplemented with
protease inhibitor cocktail. The protein concentrations of the
supernatants were determined by BCA assay (Pierce). Samples
were boiled in SDS-PAGE sample buffer (62.5 mM Tris-HCl,
pH 6.8; 2%SDS; 10% glycerol; 0.1% bromophenol blue) with b-
ME and separated by SDS-PAGE. Proteins were transferred to
polyvinylidene difluoride membranes, blocked in 2% (wt/vol) milk
in PBS, and immunoblotted with the indicated antibodies and
appropriate horseradish peroxidase-conjugated secondary anti-
bodies. Antibodies used are rabbit anti-GFP antibody (Abcam),
rabbit anti-I-Aa serum (JV1), rabbit anti-I-Ab serum (JV2) [22],
anti-p97 (Fitzgerald Industries International). Following three
washes in PBS-Tween 20 (0.1%), the blots were developed using
Western Lighting Chemiluminescence Reagent (Perkin-Elmer).
Antigen presentation assay
Day 5 BMDCs were incubated with ovalbumin at the
concentrations and times indicated, BMDCs were subsequently
fixed with 3% paraformaldehyde and then extensively washed. T
cells were isolated from the lymph nodes and spleens of OT-II
mice using the Pan T Cell Isolation Kit (Milteni Biotec). T cells
were incubated with fixed BMDCs overnight. Cells were harvested
by pipetting and were stained for flow cytometry with vb5.1+5.2-
Figure 6. Antigen presentation efficiency is normal in I-A-b-
K225R-EGFP BMDCs. A, BMDCs were incubated with the indicated
concentrationsofovalbumin (Ova) for one hour and subsequently fixed. T
cells from OTII mice were incubated with the fixed BMDCs overnight and
upregulation of CD69 onT cells was assessedby flow cytometry. B,A s s a y s
were performed as in A. BMDCs were incubated with 2 mg/ml Ova for the
indicatedtimes priortofixation.Theseexperimentswereperformedtwice
with a total of 4 mice of each genotype; representative data are shown.
doi:10.1371/journal.pone.0018817.g006
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collected on FACS Calibur flow cytometer (BD Biosciences) and
analyzed with FlowJo software (TriStar). Cells were gated on CD4
positive cells and analyzed for surface expression of CD69.
Immunizations
On day 1 mice were immunized intraperitoneally with 10 mg
each of Ovalbumin (Ova) and lysozyme (HEL) mixed with
complete Freund’s adjuvant (Sigma) and on day 21 with 10 mg
each of Ova and HEL mixed with incomplete Freund’s adjuvant.
Sera were collected on day 0 and 28 for analysis by ELISA.
Influenza infections
Mice were anesthetized by a single dose of 0.4–0.6 mg/g body
weight of avertin (1.25% tribomoethanol, GIBCO), delivered by
intraperitoneal injection. Infections were accomplished by intranasal
instillation of influenza virus (Influenza A/PR8/34 or Influenza A/
WSN/33) in up to 50 ml of PBS over a 10 minutes period. Weight of
infected animals was monitored daily. Blood was extracted from the
tail vein or by cardiac puncture after the animals were sacrificed.
ELISAs
Plates were coated with either anti-mouse Ig antibodies
(Southern Biotech), Ova, HEL or whole influenza particles.
Bound antibodies were detected with HRP-conjugated isotype
specific antibodies (Southern Biotech). ELISA plates were read
using SpectraMax M2 microplate reader (Molecular Devices).
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